Neural mechanisms of tolerance to the effects of cocaine

Behavioural Brain Research

Volumn 84, Issue 1-2, 1997, Pages 225-239

  Hammer Jr , Ronald P ^a,c   Egilmez, Yaprak ^b   Emmett Oglesby, Michael W ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH TEXAS   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

adaptation; chronic; cocaine; deoxygluco se; drug discrimination; dynorphin; immediate early gene; reinforcement; self administration; tolerance

Indexed keywords

COCAINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG TOLERANCE; IMMEDIATE EARLY GENE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0343923442     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)83332-3     Document Type: Review

References (155)

1. Abraham, W., Dragunow, M. and Tate, W., The role of immediate early genes in the stabilization of long-term potentiation, Mol. Neurobiol., 5 (1991) 297-314.
2. Ambre, J.J., Belknap, S.M., Nelson, J., Ruo, T.I., Shin, S.-G. and Atkinson, A.J., Acute tolerance to cocaine in humans, Clin. Pharmacol. Ther., 44 (1988) 1-8.
3. Asin, K.E., Bednarz, L., Nikkel, A. and Perner, R., Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa, J. Pharmacol. Exp. Ther., 273 (1995) 1483-1490.
4. Asin, K.E., Nikkel, A.L. and Wirtshafter, D., Repeated D1 receptor agonist treatment blocks cocaine-induced locomotor activity and c-fos expression, Brain Res., 637 (1994) 342-344.
5. Asin, K.E. and Wirtshafter, D., Effects of repeated dopamine D1 receptor stimulation on rotation and c-fos expression, Eur. J. Pharmacol., 235 (1993) 167-168.
6. Barrett, R.J. and Leith, N.J., Tolerance to the discriminative stimulus properties of d-amphetamine, Neuropharmacol., 20 (1981) 251-255.
7. Barrett, R.J. and White, D.K., Reward system depression following chronic amphetamine: antagonism by haloperidol, Pharmacol. Biochem. Behav., 13 (1980) 555-559.
8. Berretta, S., Robertson, H.A. and Graybiel, A.M., Dopamine and glutamate agonists stimulate neuron-specific expression of fos-like protein in the striatum, J. Neurophysiol., 68 (1992) 767-777.
9. Bhat, R.V., Cole, A.J. and Baraban, J.M., Chronic cocaine treatment suppresses basal expression of zif 268 in rat forebrain: in situ hybridization studies, J. Pharmacol. Exp. Ther., 263 (1992) 343-349.
10. Brauer, L.H., Ambre, J. and De Wit, H., Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy men, J. Clin. Psychopharmacol., 16 (1996) 72-76.
11. Brog, J.S., Salyapongse, A., Deutch, A.Y. and Zahm, D.S., The patterns of afferent innervation of the core and shell in the 'accumbens' part of the rat ventral striatum: Immunohistochemical detection of retrogradely transported fluoro-gold, J. Comp. Neurol., 338 (1993) 255-278.
12. Caine, S.B., Heinrichs, S.C., Coffin, V.L. and Koob, G.F., Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat, Brain Res., 692 (1995) 47-56.
13. 14C-2-deoxyglucose autoradiography, J. Neurosci., 8 (1988) 1951-1961.
14. Cassens, G., Actor, C., Kling, M. and Schildkraut, J.J., Amphetamine withdrawal: effects on threshold of intracranial reinforcement, Psychopharmacology, 73 (1981) 318-322.
15. Cenci, M.A., Campbell, K., Wictorin, K. and Björklund, A., Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra in the rat, Eur. J. Neurosci., 4 (1992) 376-380.
16. Cerruti, C., Pilotte, N., Uhl, G. and Kuhar, M.J., Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration, Mol. Brain Res., 22 (1994) 132-138.
17. Clow, D.W. and Hammer, R.P., Cocaine abstinence following chronic treatment alters cerebral metabolism in dopaminergic reward regions: bromocriptine enhances recovery, Neuropsychopharmacology, 4 (1991) 71-75.
18. Cole, R.L., Konradi, C., Douglass, J. and Hyman, S.E., Neuronal adaptation to amphetamine and dopamine: Molecular mechanisms of prodynorphin gene regulation in rat striatum, Neuron, 14 (1995) 813-823.
19. Cunningham, K.A., Callahan, P.M. and De la Garza, R., Limbic circuitry and neurotransmitters involved in the discriminative properties of cocaine, Behav. Pharmacol., 7 Suppl. (1996) 22.
20. Cunningham, S.T. and Kelley, A.E., Hyperactivity and sensitization to psychostimulants following cholera toxin infusion into the nucleus accumbens, J. Neurosci., 13 (1993) 2342-2350.
21. Dackis, D.A. and Gold, M.S., New concepts in cocaine addiction: The dopamine depletion hypothesis, Neurosci. Biochem. Rev., 9 (1985) 469-477.
22. Daunais, J.B. and McGinty, J.F., Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs, Mol. Brain Res., 29 (1995) 201-210.
23. Daunais, J.B., Roberts, D.C.S. and McGinty, J.F., Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum, NeuroReport, 4 (1993) 543-546.
24. Emmett-Oglesby, M.W. and Gong, Y., Effect of chronic morphine on cocaine self-administration, NIDA Res. Monogr., 141 (1994) 282.
25. Emmett-Oglesby, M.W. and Lane, J.D., Tolerance to the reinforcing effects of cocaine, Behav. Pharmacol., 3 (1992) 193-200.
26. Emmett-Oglesby, M.W., Peltier, R.L., Depoortere, R.Y., Pickering, C.L., Hooper, M.L., Gong, Y.H. and Lane, J.D., Tolerance to self-administration of cocaine in rats: Time course and dose-response determination using a multi-dose method, Drug Alcohol Depend., 32 (1993) 247-256.
27. 2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin, Brain Res., 581 (1992) 261-268.
28. Ennulat, D.J., Babb, S.M. and Cohen, B.M., Persistent reduction of immediate early gene mRNA in rat forebrain following single or multiple doses of cocaine, Brain Res., 26 (1994) 106-112.
29. Esposito, R.U., Motola, A.H.D. and Kornetsky, C, Cocaine: acute effects on reinforcement thresholds for self-stimulation behavior to the medial forebrain bundle, Pharmacol. Biochem. Behav., 8 (1978) 437-439.
30. Fischman, M.W., Schuster, C.R., Javaid, J., Hatano, T. and Davis, J., Acute tolerance development to the cardiovascular and subjective effects of cocaine, J. Pharmacol. Exp. Ther., 235 (1985) 677-682.
31. Foltin, R.Q. and Fischman, M.W., Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects, J. Pharmacol. Exp. Ther., 257 (1991) 247-261.
32. Frank, R.A., Manderscheid, P.Z., Panicker, S., Williams, H.P. and Kokoris, D., Cocaine euphoria, dysphoria, and tolerance assessed using drug-induced changes in brainstimulation reward, Pharmacol. Biochem. Behav., 42 (1992) 771-779.
33. Frank, R.A., Martz, S. and Pommering, T., The effect of chronic cocaine on self-stimulation train-duration thresholds, Pharmacol. Biochem. Behav., 29 (1988) 755-758.
34. Gawin, F. and Kleber, H., Abstinence symptomatology and psychiatric diagnosis in cocaine abusers, Arch. Gen. Psychiatry, 43 (1986) 107-113.
35. Gawin, F.H., Cocaine addiction: psychology and neurophysiology, Science, 251 (1991) 1580-1586.
36. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons, Science, 250 (1990) 1429-1432.
37. Gerfen, C.R., Keefe, K.A. and Gauda, E.B., Dl and D2 dopamine receptor function in the striatum: Co-activation of Dl-and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons, J. Neurosci., 15 (1995) 8167-8176.
38. Gerfen, C.R. and Young, I., W.S., Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study, Brain Res., 460 (1988) 161-167.
39. Ghosh, A. and Greenberg, M.E., Calcium signaling in neurons: molecular mechanisms and cellular consequences, Science, 268 (1995) 239-247.
40. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M. and Caron, M.G., Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter, Nature, 379 (1996) 606-612.
41. Goeders, N.E. and Kuhar, M.J., Chronic cocaine administration induces opposite changes in dopamine receptors in the striatum and nucleus accumbens, Alcohol Drug Res., 7 (1987) 207-216.
42. Grant, S., Newlin, D., Villemagne, V., Phillips, R.L., Liu, X., Kimes, A.S., Contorreggi, C. and London, E.D., Cerebral glucose metabolism during cocaine craving: a PET FDG study, Soc. Neurosci. Abstr., 21 (1995) 1956.
43. Graybiel, A.M., Moratalla, R. and Robertson, H.A., Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome matrix compartments and limbic subdivisions of the striatum, Proc. Natl. Acad. Sci. USA, 87 (1990) 6912-6916.
44. Griffiths, R.R., Bigelow, G.E. and Henningfield, J.R., Similarities in animal and human drug taking behavior. In N.K. Mello (Ed.), Advances in Substance Abuse: Behavioral and Biological Research, JAI Press, Greenwich, 1980, pp. 1-90.
45. Hammer, R.P. and Cooke, E.S., Gradual tolerance of metabolic activity is produced in mesolimbic regions by chronic cocaine treatment, while subsequent cocaine challenge activates extra-pyramidal regions of rat brain, J. Neurosci., 14 (1994) 4289-4298.
46. Hammer, R.P., Pires, W.S., Markou, A. and Koob, G.F., Withdrawal following cocaine self-administration decreases regional cerebral metabolic rate in critical brain reward regions, Synapse, 14 (1993) 73-80.
47. Hanbauer, I., Kennedy, L.T., Missale, C. and Bruckwick, E.C., Cocaine binding sites located in striatal membranes are regulatory sites for dopaminergic synapses. In G. Biggio, P.F. Spano, G. Toffano and G.L. Gessa (Eds.), Neuromodulation and Brain Function, Pergamon Press, Oxford, 1984, pp. 41-49.
48. Heidbreder, C.A., Goldberg, S.R. and Shippenberg, T.S., The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat, Brain Res., 616 (1993) 335-338.
49. Heidbreder, C.A. and Shippenberg, T.S., U-69593 prevents cocaine sensitization by normalizing basal accumbens dopamine, NeuroReport, 5 (1994) 1797-1800.
50. Henry, D.J. and White, F.J., Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens, J. Pharmacol. Exp. Ther., 258 (1991) 882-889.
51. Hersch, S.M., Ciliax, B.J., Gutekunst, C.A., Rees, H.D., Heilman, C.J., Yung, K.K.L., Bolam, J.P., Ince, E., Yi, H. and Levey, A.I., Electron microscopic analysis of Dl and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents, J. Neurosci., 15 (1995) 5222-5237.
52. Hurd, Y.L. and Herkenham, M., Molecular alterations in the neostriatum of human cocaine addicts, Synapse, 13 (1993) 357-369.
53. Hurd, Y.L. and Ungerstedt, U., Cocaine: An in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum, Synapse, 3 (1989) 48-54.
54. Hurd, Y.L., Weiss, E., Koob, G.F., Anden, N.-E. and Ungerstedt, U., Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study, Brain Res., 498 (1989) 199-203.
55. Hutchings, G.C., Gonzales, L.P. and Altshuler, H.L., Changes in cocaine discrimination in rats during chronic cocaine exposure, Fed. Proc., 37 (1978) 274.
56. Hyman, S.E., Cole, R.L., Konradi, C. and Kosofsky, B.E., Dopamine regulation of transcription factor-target interactions in rat striatum, Chem. Senses, 20 (1995) 257-260.
57. Imperato, A., Mele, A., Scrocco, M.G. and Puglisi, A.S., Chronic cocaine alters limbic extracellular dopamine. Neurochemical basis for addiction, Eur. J. Pharmacol., 212 (1992) 299-300.
58. Inada, T., Polk, K., Purser, C., Hume, A., Hoskins, B., Ho, I.K. and Rockhold, R.W., Behavioral and neurochemical effects of continuous infusion of cocaine in rats, Neuropharmacology, 31 (1992) 701-708.
59. Izenwasser, S. and Cox, B.M., Inhibition of dopamine uptake by cocaine and nicotine: Tolerance to chronic treatments, Brain Res., 573 (1992) 119-125.
60. Jaffe, J.H., Drug addiction and drug abuse. In A.G. Gilman, L.S. Goodman, T.W. Rall and F. Murad (Eds.), The Pharmacological Basis of Therapeutics, Pergamon Press, Elmsford, 1990, pp. 522-573.
61. Karoum, F., Suddath, R.L. and Wyatt, R.J., Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism, Eur. J. Pharmacol., 186 (1990) 1-8.
62. Katz, J.L., Griffiths, J.W., Sharpe, L.G., De Souza, E.B. and Witkin, J.M., Cocaine tolerance and cross-tolerance, J. Pharmacol. Exp. Ther., 264 (1993) 183-192.
63. Kawaguchi, Y., Wilson, C.J. and Emson, P.C., Projection sub-types of rat neostriatal matrix cells revealed by intracellular injection of biocytin, J. Neurosci., 10 (1990) 3421-3438.
64. Keys, A. and Ellison, G., Continuous cocaine induces persisting alterations in dopamine overflow in caudate following perfusion with a Dl agonist, J. Neural Transm., 97 (1994) 225-233.
65. 2 receptor function, J. Pharmacol. Exp. Ther., 269 (1994) 743-749.
66. King, G.R., Joyner, C., Lee, T.H., Kuhn, C. and Ellinwood, E.H., Intermittent and continuous cocaine administration: residual behavior states during withdrawal, Pharmacol. Biochem. Behav., 43 (1992) 243-248.
67. King, G.R., Kuhn, C. and Ellinwood, E.H., Dopamine efflux during withdrawal from continuous or intermittent cocaine, Psychopharmacology, 111 (1993) 179-184.
68. Kleber, H.D. and Gawin, F.H., Pharmacological treatments of cocaine abuse. In A.M. Washton and M.S. Gold (Eds.), Cocaine: A Clinician's Handbook, Guilford Press, New York, 1987, pp. 118-137.
69. Kleven, M.S., Woolverton, W.L. and Seiden, L.S., Lack of long-term monoamine depletions following repeated or continuous exposure to cocaine, Brain Res. Bull., 21 (1988) 233-237.
70. Kokkinidis, L. and McCarter, B.D., Postcocaine depression and sensitization of brain-stimulation reward: analysis of reinforcement and performance effects, Pharmacol. Biochem. Behav., 36 (1990) 463-471.
71. Kokkinidis, L., Zacharko, R.M. and Predy, P.A., Post-amphet-amine depression of self-stimulation responding from the substantia nigra, Pharmacol. Biochem. Behav., 13 (1980) 379-383.
72. Koob, G.F. and Bloom, F.E., Cellular and molecular mechanisms of drug dependence, Science, 242 (1988) 715-723.
73. Kornetsky, C. and Esposito, R.U., Euphorigenic drugs: effects on the reward pathways of the brain, Fed. Proc., 38 (1979) 2473-2476.
74. Kornetsky, C., Huston-Lyons, D. and Porrino, L.J., The role of the olfactory tubercle in the effects of cocaine, morphine and brain-stimulation reward, Brain Res., 541 (1991) 75-81.
75. Leith, N.J. and Barrett, R.J., Amphetamine and the reward system: evidence for tolerance and post-drug depression, Psychopharmacology, 46 (1976) 19-25.
76. Leith, N.J. and Barrett, R.J., Self-stimulation and amphetamine: tolerance to d and l isomers and cross tolerance to cocaine, Psychopharmacology, 74 (1981) 23-28.
77. Li, D.H., Depoortere, R.Y. and Emmett-Oglesby, M.W., Tolerance to the reinforcing effects of cocaine in a progressive ratio paradigm, Psychopharmacology, 116 (1994) 326-332.
78. Little, K.Y., Kirkman, J.A., Carroll, F.I., Clark, T.B. and Duncan, G.E., Cocaine use increases [3H]WIN 35428 binding sites in human striatum, Brain Res., 628 (1993) 17-25.
79. London, E.D., Cascella, N.G., Wong, D.F., Phillips, R.L., Dannals, R.F., Links, J.M., Herning, R., Grayson, R., Jaffe, J.H. and Wagner, H.N., Cocaine-induced reduction of glucose utilization in human brain - A study using positron emission tomography and [Fluorine-18]fluorodeoxyglucose., Arch. Gen. Psychiatr., 47 (1990) 567-574.
80. London, E.D., Wilkerson, G., Goldberg, S.R. and Risner, M.E., Effects of L-cocaine on local cerebral glucose utilization in the rat, Neurosci. Lett., 68 (1986) 73-78.
81. Maisonneuve, I.M., Ho, A. and Kreek, M.J., Chronic administration of a cocaine 'binge' alters basal extracellular levels in male rats: An in vivo microdialysis study, J. Pharmacol. Exp. Ther., 272 (1995) 652-657.
82. Maisonneuve, I.M. and Kreek, M.J., Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats: An in vivo microdialysis study, J. Pharmacol. Exp. Ther., 268 (1994) 916-921.
83. Maldonado, R., Robledo, P., Chover, A.J., Caine, S.B. and Koob, G.F., D1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat, Pharmacol. Biochem. Behav., 45 (1993) 239-242.
84. Markou, A. and Koob, G.F., Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal, Neuropsychopharmacology, 7 (1992) 213-224.
85. Markou, A. and Koob, G.F., Postcocaine anhedonia. An animal model of cocaine withdrawal, Neuropsychopharmacology, 4 (1991) 17-26.
86. 3H] dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats, J. Pharmacol. Exp. Ther., 270 (1994) 133-141.
87. McCowen, T.J. and Barrett, R.J., Development of tolerance to the rewarding effects of self-administered (+)-amphetamine, Pharmacol. Biochem. Behav., 12 (1980) 137-141.
88. McKenna, M. and Ho, B.T., Induced tolerance to the discriminative stimulus properties of cocaine, Pharmacol. Biochem. Behav., 47 (1977) 153-155.
89. Meiergerd, S.M., Hooks, S.M. and Schenk, J.O., The striatal transporter for dopamine in the rat may be kinetically up-regulated following 3 weeks of withdrawal from cocaine self-administration, J. Neurochem., 63 (1994) 1277-1281.
90. Miserendino, M.J.D. and Nestler, E.J., Behavioral sensitization to cocaine: Modulation by the cyclic AMP system in the nucleus accumbens, Brain Res., 674 (1995) 299-306.
91. Mogenson, G.J. and Yang, C.R., The contribution of basal ganglia to limbic-motor integration and the mediation of motivation to action. In T.C. Napier, P.W. Kalivas and I. Hamin (Eds.), The Basal Ganglia: Anatomy to Function, Plenum Press, New York, 1991, pp. 267-290.
92. Moratalla, R., Graybiel, A.M. and Robertson, H.A., Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum, J. Neurosci., 12 (1992) 2609-2622.
93. Morgan, J.I. and Curran, T., Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun, Annu. Rev. Neurosci., 14 (1991) 421-451.
94. Neisewander, J.L., Lucki, I. and McGonigle, P., Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats, Synapse, 16 (1994) 1-10.
95. 0α in discrete regions of rat brain, J. Neurochem., 55 (1990) 1079-1082.
96. Olds, M.E. and Fobes, J.L., The central basis of motivation: intracranial self-stimulation studies, Annu. Rev. Psychol., 32 (1981) 523-574.
97. Parsons, L.H., Koob, G.F. and Weiss, F., Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine, J. Pharmacol. Exp. Ther., 274 (1995) 1182-1192.
98. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd Edn., Academic Press, New York, 1986.
99. Pearlson, G.D., Jeffery, P.J., Harris, G.J., Ross, C.A., Fischman, M.W. and Camargo, E.E., Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects, Am. J. Psychiatry, 150 (1993) 495-497.
100. Peltier, R.L., Li, D.H., Lytle, D., Taylor, C.M. and Emmett-Oglesby, M.W., Chronic d-amphetamine or methamphetamine produces cross-tolerance to the discriminative and reinforcing stimulus effects of cocaine, J. Pharmacol. Exp. Ther., 277 (1996) 212-218.
101. Peris, J., Boyson, S.A., Cass, W.A., Curella, P., Dwoskin, L.P., Larson, G., Lin, L.-H., Uasuda, R.P. and Zahniser, N.R., Persistence of neurochemical changes in dopamine systems after repeated cocaine administration, J. Pharmacol. Exp. Ther., 253 (1990) 38-44.
102. Persico, A.M., Schindler, C.W., O'Hara, B.F., Brannock, M.T. and Uhl, G.R., Brain transcription factor expression: Effects of acute and chronic amphetamine and injection stress, Mol. Brain Res., 20 (1993) 91-100.
103. Pilotte, N.S., Sharpe, L.G. and Kuhar, M.J., Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats, J. Pharmacol. Exp. Ther., 269 (1994) 963-969.
104. Porrino, L.J., Functional consequences of acute cocaine treatment depend on route of administration, Psychopharmacology, 112 (1993) 343-351.
105. Post, R.M., Lockfeld, A., Squillace, K.M. and Contel, N.R., Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization, Life Sci., 28 (1981) 755-760.
106. Preston, K.L. and Bigelow, G.E., Subjective and discriminative effects of drugs, Behav. Pharmacol., 2 (1991) 293-313.
107. Reith, M.E., Benuck, M. and Lajtha, A., Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice, J. Pharmacol. Exp. Ther., 243 (1987) 281-287.
108. Robertson, G.S. and Jian, M., D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain, Neurosci., 64 (1995) 1019-1034.
109. Robertson, G.S., Vincent, S.R. and Fibiger, H.C., D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons, Neuroscience, 49 (1992) 285-296.
110. Robinson, T.E. and Berridge, K.C., The neural basis of drug craving: an incentive-sensitization theory of addiction, Brain Res. Rev., 18 (1993) 247-291.
111. Sagar, S.M., Sharp, F.R. and Curran, T., Expression of c-fos protein in brain: metabolic mapping at the cellular level, Science, 240 (1988) 1328-1331.
112. Schuster, C.R., Dockens, W.S. and Woods, J.H., Behavioral variables affecting the development of amphetamine tolerance, Psychopharmacology, 9 (1966) 170-182.
113. Schuster, C.R. and Johanson, C.E., Relationship between the discriminative stimulus properties and subjective effects of drugs. In F.C. Colpaert and R.L. Balster (Eds.), Transduction Mechanisms of Drug Stimuli, Springer-Verlag, Berlin, 1988, pp. 161-175.
114. Schwartz, W.J., Sharp, F.R., Gunn, R.H. and Evarts, E.V., Lesions of ascending dopaminergic pathways of decrease forebrain glucose uptake, Nature, 261 (1976) 155-157.
115. Siegel, S., Alcohol and opiate dependence: Re-evaluation of the Victorian perspective. In H.D. Cappell, F.B. Glaser, Y. Israel, H. Kalant, W. Schmidt, E.N. Sellers and R.C. Smart (Eds.), Research Advances in Alcohol and Drug Dependence, Plenum Press, New York, 1986, pp. 279-314.
116. Siegel, S., Pharmacological conditioning and drug effects. In A.J. Goudie and M.W. Emmett Oglesby (Eds.), Psychoactive Drugs Tolerance and Sensitization, Humana Press, Clifton, 1989, pp. 115-169.
117. Spangler, R., Unterwald, E.M. and Kreek, M.J., 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen, Mol. Brain Res., 19 (1993) 323-327.
118. Staley, J.K., Hearn, W.L., Ruttenber, A.J., Wetli, C.V. and Mash, D.C., High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims, J. Pharmacol. Exp. Ther., 271 (1994) 1678-1685.
119. Steiner, H. and Gerfen, C.R., Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum, J. Neurosci., 13 (1993) 5066-5081.
120. Steiner, H. and Gerfen, C.R., Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum, J. Comp. Neurol., 353 (1995) 200-212.
121. Stewart, J. and Badiani, A., Tolerance and sensitization to the behavioral effects of drugs, Behav. Pharmacol., 4 (1993) 289-312.
122. 1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons, Neuron, 14 (1995) 385-397.
123. Taber, M.T. and Fibiger, H.C., Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: Modulation by metabotropic glutamate receptors, J. Neurosci., 15 (1995) 3896-3904.
124. Taylor, D. and Ho, B.T., Neurochemical effects of cocaine following acute and repeated injection, J. Neurosci. Res., 3 (1977) 95-101.
125. Terwilliger, R.Z., Beitner-Johnson, D., Sevarino, K.A., Crain, S.M. and Nestler, E.J., A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function, Brain Res., 548 (1991) 100-110.
126. Thomas, W.L., Cooke, E.S. and Hammer, R.P., Pretreatment with a dopamine D1 receptor antagonist prevents metabolic activation by cocaine, Neurosci. Lett., 196 (1995) 161-164.
127. Thompson, R.F. and Spencer, W.A., Habituation: a model phenomenon for the study of neuronal substrates of behavior, Psychol. Rev., 73 (1966) 16-43.
128. Torres, G. and Rivier, C., Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists, Brain Res. Bull., 30 (1993) 173-176.
129. Torres, G., Rivier, C. and Weiss, F., A ketamine mixture anesthetic inhibits neuroendocrine and behavioral consequences of cocaine administration, Brain Res., 656 (1994) 33-42.
130. Trugman, J.M. and Wooten, G.F., Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantial nigra lesions, J. Neurosci., 7 (1987) 2927-2935.
131. Trulson, M.E., Joe, J.C., Babb, S. and Raese, J.D., Chronic cocaine administration depletes tyrosine hydroxylase immunoreactivity in the mesolimbic dopamine system in rat brain: quantitative light microscopic studies, Brain Res. Bull., 19 (1987) 39-45.
132. 3H]spiperidol binding in rat brain, Brain Res. Bull., 19 (1987) 35-38.
133. Volkow, N.D., Fowler, J.S., Wang, G.J., Hitzemann, R., Logan, J., Schlyer, D.J., Dewey, S.L. and Wolf, A.P., Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers, Synapse, 14 (1993) 169-177.
134. Volkow, N.D., Hitzemann, R., Wang, G.-J., Fowler, J.S., Wolf, A.P., Dewey, S. and Handlesman, L., Long-term frontal brain metabolic changes in cocaine abusers, Synapse, 11 (1992) 184-190.
135. Volkow, N.D., Mullani, N., Gould, K.L., Adler, S. and Krajewski, K., Cerebral blood flow in chronic cocaine users: a study with positron emission tomography, Br. J. Psychiatry, 152 (1988) 641-648.
136. Wechsler, L.R., Savaki, H.E. and Sokoloff, L., Effects of d-and l-amphetamine on local cerebral glucose utilization in the conscious rat, J. Neurochem., 32 (1979) 15-22.
137. Weiss, F., Markou, A., Lorang, M.T. and Koob, G.F., Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration, Brain Res., 593 (1992) 314-318.
138. Weiss, F., Paulus, M.P., Lorang, M.T. and Koob, G.F., Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: effects of acute and repeated administration, J. Neurosci., 12 (1992) 4372-4380.
139. Willner, P., The validity of animal models of depression, Psychopharmacology, 83 (1984) 1-16.
140. Wirtshafter, D. and Asin, K.E., Interactive effects of stimulation of D1 and D2 dopamine receptors on fos-like immunoreactivity in the normosensitive rat striatum, Brain Res. Bull., 35 (1994) 85-91.
141. Wise, R.A. and Munn, E., Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds, Psychopharmacology, 117 (1995) 130-136.
142. Wise, R.A. and Rompre, P.P., Brain dopamine and reward, Annu. Rev. Psychol., 40 (1989) 191-225.
143. Wolgin, D.L., The role of instrumental learning in behavioral tolerance to drugs. In A.J. Goudie and M.W. Emmett Oglesby (Eds.), Psychoactive Drugs Tolerance and Sensitization, Humana Press, Clifton, 1989, pp. 17-114.
144. Wood, D.M. and Emmett-Oglesby, M.W., Characteristics of tolerance recovery from tolerance and cross-tolerance to cocaine used as a discriminative stimulus, J. Pharmacol. Exp. Ther., 237 (1986) 120-125.
145. Wood, D.M. and Emmett-Oglesby, M.W., Mediation in the nucleus accumbens of the discriminative stimulus produced by cocaine, Pharmacol. Biochem. Behav., 33 (1989) 453-457.
146. Wood, D.M. and Emmett-Oglesby, M.W., Substitution and cross-tolerance profiles of anorectic drugs in rats trained to detect the discriminative stimulus properties of cocaine, Psychopharmacology, 95 (1988) 364-368.
147. Wood, D.M., Lal, H. and Emmett-Oglesby, M.W., Acquisition and recovery of tolerance to the discriminative simulus properties of cocaine, Neuropharmacology, 23 (1984) 1419-1423.
148. Woolverton, W.L., Kandel, D. and Schuster, C.R., Tolerance and cross-tolerance to cocaine and d-amphetamine, J. Pharmacol. Exp. Ther., 205 (1978) 525-535.
149. Worley, P.F., Christy, B.A., Nakabeppu, Y., Bhat, R.V., Cole, A.J. and Baraban, J.M., Constitutive expression of zif268 in neocortex is regulated by synaptic activity, Proc. Natl. Acad. Sci. USA, 88 (1991) 5106-5110.
150. Yanagita, T., An experimental framework for evaluation of dependence liability of various types of drugs in, Bull. Narcot., 25 (1973) 57-64.
151. Yeh, S.Y. and De Souza, E.B., Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on brain monoamine neurons, Drug Alcohol Depend., 27 (1991) 51-61.
152. 3H]dopamine, Neuropharmacology, 29 (1990) 475-486.
153. You, Z.B., Herrera-Marschitz, M., Nylander, I., Goiny, M., O'Connor, W.T., Ungerstedt, U. and Terenius, L., The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis-II. Effects of dopamine D1 and D2 receptor agonists, Neuroscience, 63 (1994) 427-434.
154. Young, A.M., Walton, M.A. and Carter, T.L., Selective tolerance to discriminative stimulus effects of morphine or d-amphetamine, Behav. Pharmacol., 3 (1992) 201-209.
155. 1 receptors, Proc. Natl. Acad. Sci. USA, 88 (1991) 1291-1295.